ClinTec CEO shortlisted for Scottish Entrepreneur of the Year award
3 June 2010
Dr Rabinder Buttar of ClinTec International, the Global
Clinical Research Organisation, has been shortlisted by Ernst & Young
for the 2010 entrepreneur of the year award.
The successful candidate will be announced in June, with the
winner going through to the UK finals in London this October. The
accolade is specifically designed to recognise and reward the
achievements of business executives that drive the UK's most
innovative enterprises. This year’s finalists’ were shortlisted
according to proven ability to adapt and grow their businesses in
the current challenging market conditions — exemplified by the
expansion of ClinTec into 17 new countries and the achievement of
2009 global revenue growth of 45%.
Dr Buttar launched ClinTec in 1997 from her home and this year
the company continued to achieve high growth and has opened further
new offices as part of its expansion programme. With its fast and
flexible approach to drug development, ClinTec is now present in 40
countries with a client base that includes leading brands across the
biotech and pharmaceutical industries.
Moreover, the company launched its first ever global academy,
focussing on training clinical research personnel in the emerging
markets, at the recent PABME (Pharmaceutical and Biotechnology
Middle East) conference and its first 13 students successfully
completed their ICH-GCP course certified by the Dubai Health
Authorities.
Jim Bishop, partner and Scotland Entrepreneur of the Year leader
at Ernst & Young, said: “This year’s finalists have shown their
ability to adapt to market conditions by seizing opportunities and
taking market share in the toughest of times. They have maintained
their vision for growth and pursued it, increased their focus on
customer satisfaction and loyalty, expanded into new segments and
geographical markets and engaged their employees using greater
communication and transparency.”
ClinTec International’s CEO, Dr Rabinder Buttar commenting on the
latest ClinTec landmark, said: “This latest award is just further
proof of the dramatic strides ClinTec International has made over
the past year. Our fast and flexible approach to drug development is
enjoying high recognition as we have expanded our international
presence, grown in emerging markets and continued to harness an
entrepreneurial and innovative spirit that drives our employees.”